Cancer News and Research

Latest Cancer News and Research

New gene classifier can predict the risk of cancer cells recurring or progressing

New gene classifier can predict the risk of cancer cells recurring or progressing

Study challenges a long-standing idea about the role of Hippo signaling in organ growth

Study challenges a long-standing idea about the role of Hippo signaling in organ growth

New AI blood testing technology detects more than 80% of liver cancers

New AI blood testing technology detects more than 80% of liver cancers

β-cyclodextrin family found to be promising and cost-effective antiviral agents against SARS-CoV-2

β-cyclodextrin family found to be promising and cost-effective antiviral agents against SARS-CoV-2

Pt(IV)-conjugated drug-delivery system shows efficacy in glioblastoma therapy

Pt(IV)-conjugated drug-delivery system shows efficacy in glioblastoma therapy

New therapeutic windows for developing effective treatments for metastatic tumors

New therapeutic windows for developing effective treatments for metastatic tumors

Scientific gathering aims to integrate advances in cancer and aging research

Scientific gathering aims to integrate advances in cancer and aging research

MGI announces European launch of new MGISP-Smart 8 automated sample preparation system and empowerment program at MEDICA to further access to genomics

MGI announces European launch of new MGISP-Smart 8 automated sample preparation system and empowerment program at MEDICA to further access to genomics

Benign breast disease is a key indicator of a higher risk of breast cancer

Benign breast disease is a key indicator of a higher risk of breast cancer

Protection afforded by SARS-CoV-2 infection against reinfection when Omicron BA.5 was the dominating subvariant in Scania county, Sweden

Protection afforded by SARS-CoV-2 infection against reinfection when Omicron BA.5 was the dominating subvariant in Scania county, Sweden

National Institutes of Health funds a five-year, $11 million initiative

National Institutes of Health funds a five-year, $11 million initiative

Augmented drug preferentially eliminates cancer cells but does not harm healthy cells

Augmented drug preferentially eliminates cancer cells but does not harm healthy cells

Study of natural killer lymphocytes transcriptionally reprogrammed by vaccinia virus

Study of natural killer lymphocytes transcriptionally reprogrammed by vaccinia virus

Mothers of younger or multiple children may engage in lower amounts of physical activity

Mothers of younger or multiple children may engage in lower amounts of physical activity

Modified CEUS criteria using perfluorobutane can help diagnose high-risk hepatocellular carcinoma

Modified CEUS criteria using perfluorobutane can help diagnose high-risk hepatocellular carcinoma

Researchers discover the mechanism for heart complications from immune checkpoint inhibitors

Researchers discover the mechanism for heart complications from immune checkpoint inhibitors

Collaborative project focuses on improving access to breast cancer care in Argentina

Collaborative project focuses on improving access to breast cancer care in Argentina

Scientists develop new injectable hydrogel for treatment of aneurysms

Scientists develop new injectable hydrogel for treatment of aneurysms

Machine learning algorithm predicts a tumor’s response to immune checkpoint blockade

Machine learning algorithm predicts a tumor’s response to immune checkpoint blockade

Study could form the basis of blood testing for people at high risk of breast cancer

Study could form the basis of blood testing for people at high risk of breast cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.